Agilent names senior vice president of Strategy and Corporate Development
Illumina launches tumor mutational burden and microsatellite instability assay for NGS
Berkeley Lights Raises New Funding
Academic R&D expenditure grows nearly 2% in 2017
Positive outlook for oil, gas and chemical industry
Malvern Panalytical leads in microcalorimetry market
Top 1000 innovative companies’ R&D spending jumps double digits in 2018
Survey examines labs’ instrument service preferences
Illumina, PerkinElmer and Thermo Fisher Scientific thrive while other companies receive soft sales for the third quarter
Latest sales, operating income and net profit figures for analytical instrument and laboratory product companies
Pay Invoice
Latest Blogs
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.